ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $45 | +12.5% | 12,322 | 0.0% | 0.00% | – |
Q1 2024 | $40 | -33.3% | 12,322 | 0.0% | 0.00% | – |
Q4 2023 | $60 | -86.0% | 12,322 | -58.5% | 0.00% | -100.0% |
Q3 2023 | $428 | +415.7% | 29,656 | +140.7% | 0.00% | – |
Q2 2023 | $83 | -23.9% | 12,322 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $109 | +16.0% | 12,322 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $94 | -99.9% | 12,322 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $88,000 | -12.0% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $100,000 | -41.5% | 12,322 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $171,000 | -50.6% | 12,322 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $346,000 | -17.4% | 12,322 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $419,000 | -16.7% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $503,000 | +1.4% | 12,322 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $496,000 | -32.0% | 12,322 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $729,000 | +21.7% | 12,322 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $599,000 | +0.5% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $596,000 | – | 12,322 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
Triatomic Management LP | 98,555 | $316,362 | 0.59% |
Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |